🔎 Trials Near Me

Home › Scleroderma › North Carolina › Durham

Pag-aaral pangklinika para sa Scleroderma sa Durham, NC

Isang pag-aaral para sa Scleroderma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Durham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Nagre-recruitPhase 1
  • Duke University Medical Center, Durham
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07085104

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Nagre-recruitPhase 1
  • University of North Carolina TraCS Institute - CTRC, Chapel Hill · 10 mi ang layo
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06925542

Platform Clinical Study for Conquering Scleroderma

Nagre-recruitPhase 2
  • Duke University Medical Center, Durham
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Nagre-recruitPhase 2/3
  • Duke University, Durham
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06328777

A Study of AZD0120 in Autoimmune Diseases

Nagre-recruitPhase 1
  • Research Site, Chapel Hill · 10 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT07295847

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Nagre-recruitPhase 1
  • Duke University, Durham
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT07115745

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

Nagre-recruitPhase 1
  • Duke University Health System, Durham
Edad 12 hanggang 70 · Lahat ng kasarian · Na-update May 22, 2026 · NCT06308978

Pag-aaral para sa Scleroderma sa ibang lungsod

Iba pang pag-aaral sa Durham

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.